3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
4
Withdrawn
1
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Genitourinary
1
Conditions
Multiple Myeloma
1
Infections
1
Interventions
Dexamethasone
70
Cyclophosphamide
44
Bortezomib
41
Lenalidomide
25
Melphalan
24
Thalidomide
19
pomalidomide
17
daratumumab
14
fludarabine
13
carfilzomib
10
Filgrastim
8
Doxorubicin
8
Busulfan
6
isatuximab
5
Prednisone
5
Peripheral Blood Stem Cell Transplantation
5
Calcium Dobesilate
5
Bendamustine Hydrochloride
5
selinexor
4
sargramostim
4
fludarabine phosphate
4
Surveys and Questionnaires
4
Etoposide
4
Clarithromycin
4
liposomal doxorubicin
3
ixazomib
3
dexamethasone acetate
3
Radiotherapy
3
Neoadjuvant Therapy
3
Mycophenolic Acid
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Trimethoprim, Sulfamethoxazole Drug Combination
×
Plasma cell
×
Clear all
NCT02624440
2015-12-08
SUTRICA
Aalborg University Hospital
Phase 2
Unknown
300 enrolled